Business Context and Reporting Period
Flotek Industries, Inc. (FTK) filed this Form 8-K on May 9, 2022, to report the results of a special meeting of stockholders held on the same date. The meeting addressed a strategic contract expansion with ProFrac Holdings, LLC, the issuance of convertible debt, and corporate governance amendments.
Key Financial Metrics
This filing is a current report regarding corporate actions and does not contain financial statements. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Corporate Actions
Stockholders approved four key proposals with the following results based on 44,002,015 shares voted (57.41% of outstanding shares):
- Proposal 1 (Approved): Approval of the Securities Purchase Agreement with ProFrac Holdings, LLC, including the issuance of 10% Convertible PIK Notes and associated common stock.
- Proposal 2 (Approved): Authorization to increase the company's authorized common stock by 100,000,000 shares.
- Proposal 3 (Approved): Authorization for a reverse stock split of common stock at a ratio between 1-for-2 and 1-for-4.
- Proposal 4 (Approved): Authorization to adjourn the meeting to solicit additional proxies if necessary.
Following approval, the Company intends to close the transactions, which include expanding the Chemical Products Supply Agreement to a minimum baseline of 30 hydraulic fracturing fleets with a ten-year term.
Guidance, Outlook, and Risks
The filing indicates the Company's intent to proceed with the ProFrac contract expansion and debt issuance immediately following shareholder approval. No specific financial guidance, forward-looking revenue projections, or detailed risk factors are disclosed in this specific 8-K text beyond the standard execution of the approved agreements.
Investor Verification Checklist
- Verify the final terms of the 10% Convertible PIK Notes and the conversion price of the associated common stock.
- Confirm the specific reverse stock split ratio selected by the Board of Directors within the authorized 1-for-2 to 1-for-4 range.
- Review the definitive Chemical Products Supply Agreement to confirm the 30-fleet minimum baseline and ten-year term details.
- Monitor subsequent filings for the actual closing date of the ProFrac transaction and the issuance of the new debt and equity.